Cargando…
Therapeutic Vaccines Against Human Papillomavirus and Cervical Cancer
Cervical cancer and its precursor intra-epithelial lesions are linked to infection by a subset of so-called “highrisk” human papillomavirus types, which are estimated to infect nearly four hundred million women worldwide. Two prophylactic vaccines have been commercialized recently targeting HPV16 an...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Bentham Open
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2776308/ https://www.ncbi.nlm.nih.gov/pubmed/19915722 http://dx.doi.org/10.2174/1874357900903010067 |